| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2015PLoSO..1021099T |
| P356 | DOI | 10.1371/JOURNAL.PONE.0121099 |
| P932 | PMC publication ID | 4382154 |
| P698 | PubMed publication ID | 25830320 |
| P5875 | ResearchGate publication ID | 272417374 |
| P50 | author | Charles M. Rice | Q22669757 |
| Zabrina L Brumme | Q55135335 | ||
| Abiodun Oguntuga Ogundaini | Q58888460 | ||
| Margaret A Scull | Q61992320 | ||
| Thomas Oyebode Idowu | Q64876380 | ||
| Mark A. Brockman | Q30389078 | ||
| Fidele Ntie-Kang | Q43370925 | ||
| P2093 | author name string | David Fedida | |
| Berhanu M Abegaz | |||
| Ian Tietjen | |||
| Kerstin Andrae-Marobela | |||
| Philip Mwimanzi | |||
| Pascal Amoa Onguéné | |||
| Luc Mbaze Meva'a | |||
| P2860 | cites work | Ligand-protein docking studies of potential HIV-1 drug compounds using the algorithm FlexX. | Q51720817 |
| Natural compounds boldine and menthol are antagonists of human 5-HT3receptors: implications for treating gastrointestinal disorders | Q56971318 | ||
| Selective action of two aporphines at alpha 1-adrenoceptors and potential-operated Ca2+ channels | Q72958513 | ||
| Definition of a pharmacophore for partial agonists of serotonin 5-HT3 receptors | Q77230018 | ||
| The Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels | Q24680307 | ||
| Complete replication of hepatitis C virus in cell culture | Q27860934 | ||
| Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41 | Q28244555 | ||
| Human immunodeficiency virus type 1 cDNA integration: new aromatic hydroxylated inhibitors and studies of the inhibition mechanism | Q28368861 | ||
| Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine | Q28478569 | ||
| Virtualizing the p-ANAPL library: a step towards drug discovery from African medicinal plants | Q28540495 | ||
| The HIV-1 Vpu viroporin inhibitor BIT225 does not affect Vpu-mediated tetherin antagonism | Q28742774 | ||
| Antiviral efficacy of the novel compound BIT225 against HIV-1 release from human macrophages. | Q30968332 | ||
| Potential new anti-human immunodeficiency virus type 1 compounds depress virus replication in cultured human macrophages | Q34141302 | ||
| Anti-HIV benzylisoquinoline alkaloids and flavonoids from the leaves of Nelumbo nucifera, and structure-activity correlations with related alkaloids | Q34376435 | ||
| Integrase inhibitors to treat HIV/AIDS. | Q34397376 | ||
| Boldine and its antioxidant or health-promoting properties. | Q34459076 | ||
| The evaluation of catechins that contain a galloyl moiety as potential HIV-1 integrase inhibitors | Q34660274 | ||
| Managing HIV/hepatitis C co-infection in the era of direct acting antivirals | Q35042619 | ||
| Boldine Ameliorates Vascular Oxidative Stress and Endothelial Dysfunction: Therapeutic Implication for Hypertension and Diabetes | Q35705401 | ||
| Effects of Vpu expression on Xenopus oocyte membrane conductance | Q36896638 | ||
| Ellagic acid & gallic acid from Lagerstroemia speciosa L. inhibit HIV-1 infection through inhibition of HIV-1 protease & reverse transcriptase activity | Q36994957 | ||
| Knipholone and related 4-phenylanthraquinones: structurally, pharmacologically, and biosynthetically remarkable natural products | Q37229201 | ||
| Antiviral activity of phytochemicals: a comprehensive review | Q37294420 | ||
| HIV-1 Vpu - an ion channel in search of a job. | Q37384691 | ||
| Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis | Q37792614 | ||
| Catechins containing a galloyl moiety as potential anti-HIV-1 compounds | Q37993291 | ||
| Viral targets of acylguanidines | Q38009617 | ||
| Polyphenols: a diverse class of multi-target anti-HIV-1 agents | Q38075033 | ||
| Hepatitis C virus proteins: from structure to function | Q38086751 | ||
| Viral channel proteins in intracellular protein-protein communication: Vpu of HIV-1, E5 of HPV16 and p7 of HCV. | Q38137582 | ||
| HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study | Q38869669 | ||
| Use of a novel GFP reporter cell line to examine replication capacity of CXCR4- and CCR5-tropic HIV-1 by flow cytometry | Q38921902 | ||
| Differential effect of p7 inhibitors on hepatitis C virus cell-to-cell transmission. | Q39071173 | ||
| 2014 Update of the drug resistance mutations in HIV-1 | Q39498339 | ||
| Ion channel activity of HIV-1 Vpu is dispensable for counteraction of CD317. | Q39538757 | ||
| A novel Hepatitis C virus p7 ion channel inhibitor, BIT225, inhibits bovine viral diarrhea virus in vitro and shows synergism with recombinant interferon-alpha-2b and nucleoside analogues. | Q39739342 | ||
| Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel | Q39933785 | ||
| Cinnamoyl- and hydroxycinnamoyl amides of glaucine and their antioxidative and antiviral activities | Q39966800 | ||
| Aporphine metho salts as neuronal nicotinic acetylcholine receptor blockers | Q40153102 | ||
| Construction and in vitro properties of HIV-1 mutants with deletions in "nonessential" genes | Q41477153 | ||
| Attenuation of multiple Nef functions in HIV-1 elite controllers | Q41868799 | ||
| Genistein as antiviral drug against HIV ion channel. | Q42210207 | ||
| Antipoliovirus structure-activity relationships of some aporphine alkaloids | Q42542551 | ||
| Deletion of the vpu sequences prior to the env in a simian-human immunodeficiency virus results in enhanced Env precursor synthesis but is less pathogenic for pig-tailed macaques | Q42671868 | ||
| Reduced replication capacity of NL4-3 recombinant viruses encoding reverse transcriptase-integrase sequences from HIV-1 elite controllers | Q42718488 | ||
| Phytochemical and antimicrobial investigations of stilbenoids and flavonoids isolated from three species of Combretaceae | Q42718568 | ||
| Doubly linked, A-type proanthocyanidin trimer and other constituents of Ixora coccinea leaves and their antioxidant and antibacterial properties. | Q42906615 | ||
| Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs. | Q42984512 | ||
| Anti-herpes virus activity of aporphine alkaloids | Q43578252 | ||
| Simplified catechin-gallate inhibitors of HIV-1 reverse transcriptase | Q43759929 | ||
| Isolation and synthesis of a new bioactive ellagic acid derivative from Combretum yunnanensis | Q44450906 | ||
| Bulbinelonesides A-E, phenylanthraquinone glycosides from the roots of Bulbinella floribunda | Q44492661 | ||
| The interaction of selected natural products with human recombinant glutathione transferases | Q45186138 | ||
| Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells | Q45765997 | ||
| Natural products as potential human ether-a-go-go-related gene channel inhibitors - screening of plant-derived alkaloids | Q48599486 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | natural product | Q901227 |
| P304 | page(s) | e0121099 | |
| P577 | publication date | 2015-04-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Screening of the Pan-African natural product library identifies ixoratannin A-2 and boldine as novel HIV-1 inhibitors | |
| P478 | volume | 10 |
| Q92121433 | Application of an integrated cheminformatics-molecular docking approach for discovery for physicochemically similar analogs of fluoroquinolones as putative HCV inhibitors |
| Q115031291 | Artificial intelligence for antiviral drug discovery in low resourced settings: A perspective |
| Q89746586 | Attention/Working Memory, Learning and Memory in Adult Cameroonians: Normative Data, Effects of HIV Infection and Viral genotype |
| Q38377965 | CD4-gp120 interaction interface - a gateway for HIV-1 infection in human: molecular network, modeling and docking studies |
| Q61806079 | Capillasterin A, a Novel Pyrano[2,3-f]chromene from the Australian Crinoid |
| Q96027629 | Comatulins A-E, Taurine-Conjugated Anthraquinones from the Australian Crinoid Comatula rotalaria |
| Q55000698 | Compounds from African Medicinal Plants with Activities Against Selected Parasitic Diseases: Schistosomiasis, Trypanosomiasis and Leishmaniasis. |
| Q91572337 | Computational prospecting for pharmacological mechanism of activity: HIV-1 inhibition by Ixoratannin-A2 |
| Q38761475 | Croton megalobotrys Müll Arg. and Vitex doniana (Sweet): Traditional medicinal plants in a three-step treatment regimen that inhibit in vitro replication of HIV-1. |
| Q38602445 | Data Resources for the Computer-Guided Discovery of Bioactive Natural Products |
| Q40129798 | Evaluation of Boldine Activity against Intracellular Amastigotes of Leishmania amazonensis |
| Q50002130 | Identification of Bichalcones as Sirtuin Inhibitors by Virtual Screening and In Vitro Testing |
| Q47250374 | In silico toxicity profiling of natural product compound libraries from African flora with anti-malarial and anti-HIV properties |
| Q52687320 | Inhibition of NF-κB-dependent HIV-1 replication by the marine natural product bengamide A. |
| Q39405776 | Modeling of boldine alkaloid adsorption onto pure and propyl-sulfonic acid-modified mesoporous silicas. A comparative study |
| Q58862085 | Natural product-derived compounds in HIV suppression, remission, and eradication strategies |
| Q38752518 | Novel Acylguanidine-Based Inhibitor of HIV-1. |
| Q97067038 | Novel Histone Deacetylase Inhibitors and HIV-1 Latency-Reversing Agents Identified by Large-Scale Virtual Screening |
| Q59351133 | Pathogenic Viruses Commonly Present in the Oral Cavity and Relevant Antiviral Compounds Derived from Natural Products |
| Q90763939 | Put a cork in it: Plugging the M2 viral ion channel to sink influenza |
| Q39262249 | Sesterterpenoids Isolated from the Sponge Phorbas sp. Activate Latent HIV-1 Provirus Expression |
| Q94514020 | Structure-Activity-Relationship and Mechanistic Insights for Anti-HIV Natural Products |
| Q118139060 | Tackling the Future Pandemics: Broad-Spectrum Antiviral Agents (BSAAs) Based on A-Type Proanthocyanidins |
| Q98394142 | The African natural product knipholone anthrone and its analogue anthralin (dithranol) enhance HIV-1 latency reversal |
| Q41223576 | Unciaphenol, an Oxygenated Analogue of the Bergman Cyclization Product of Uncialamycin Exhibits Anti-HIV Activity |
| Q114865433 | Update: biological and chemical aspects of Nectandra genus (Lauraceae) |
| Q96774103 | Virtual Screening Identifies Chebulagic Acid as an Inhibitor of the M2(S31N) Viral Ion Channel and Influenza A Virus |
Search more.